文献速递乳房整形与再造

二氧化碳与盐水组织扩张器用于乳房重建的随机试验

Carbon Dioxide-Based versus Saline Tissue Expansion for Breast Reconstruction: Results of the XPAND Prospective, Randomized Clinical Trial.
PubMed 文献 · Plast Reconstr Surg · 2016-01-01

二氧化碳组治疗成功率96.1%,盐水组98.8%,总体并发症率相似;二氧化碳组至完全扩张和二期手术的中位时间更短。

要点

  • 二氧化碳扩张器治疗成功率为96.1%,盐水扩张器为98.8%。
  • 二氧化碳组至完全扩张中位21.0天,盐水组46.0天。
  • 两组总体并发症率相似,二氧化碳扩张器使用便捷性评分高。

核心结论

  • 二氧化碳扩张器是有效的组织扩张方法,总体不良事件率与盐水扩张器相似,且扩张更便捷迅速。

研究设计与样本

  • 二氧化碳组98例(168只乳房),盐水组52例(88只乳房)。

主要发现

  • 治疗成功率(排除非器械相关失败后所有乳房成功交换)二氧化碳组96.1%,盐水组98.8%。
  • 至完全扩张和二期手术完成的中位时间:二氧化碳组21.0天和108.5天,盐水组46.0天和136.5天。
  • 总体并发症率两组相似。
  • 二氧化碳扩张器使用便捷性患者评分高(98%),医生评分高(90%)。

关键数值与推荐

  • 二氧化碳组由患者以10 cc增量自行扩张,每日最多30 cc二氧化碳;盐水组由医生定期推注盐水。

临床怎么用

  • 二氧化碳扩张器可用于两阶段乳房重建的组织扩张,可能缩短扩张和二期手术时间。
  • 患者可自行控制扩张,使用便捷性高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: AeroForm is a new type of remote-controlled, needle-free, carbon dioxide-based expander involving a potentially faster method of tissue expansion. Results are presented here from the AirXpanders Patient Activated Controlled Tissue Expander pivotal trial comparing AeroForm to saline tissue expanders. METHODS: Women undergoing two-stage breast reconstruction were randomized at 17 U.S. sites in this U.S. Food and Drug Administration-approved investigational device exemption trial. Expansion in the investigational arm was performed by the patient in 10-cc increments up to 30 cc/day of carbon dioxide and in the control arm by the physician with periodic bolus injections of saline. Safety endpoints, expansion and reconstruction times, pain, and satisfaction were assessed. RESULTS: One hundred fifty women were treated: 98 with carbon dioxide expanders (n = 168) and 52 with saline expanders (n = 88). The treatment success rate (all breasts exchanged successfully excluding non-device-related failures) was 96.1 percent for carbon dioxide and 98.8 percent for saline. Median time to full expansion and completion of the second-stage operation was 21.0 and 108.5 days (carbon dioxide) versus 46.0 and 136.5 days (saline), respectively, with a similar rate of overall complications. Ease of use for the carbon dioxide expander was rated high by patients (98 percent) and physicians (90 percent). CONCLUSIONS: The AirXpanders Patient Activated Controlled Tissue Expander trial results demonstrate that a carbon dioxide-based expander is an effective method of tissue expansion with a similar overall adverse event rate compared to saline expanders, and provides a more convenient and expedient expansion. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Ascherman JA, Zeidler K, Morrison KA, et al. Carbon Dioxide-Based versus Saline Tissue Expansion for Breast Reconstruction: Results of the XPAND Prospective, Randomized Clinical Trial. Plast Reconstr Surg. 2016. PMID: 27879582. doi:10.1097/PRS.0000000000002784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。